Key Takeaways

• Across major patient review platforms (Drugs.com, WebMD, Healthline), Saxenda averages a 6.2/10 satisfaction rating based on thousands of reviews .
• The most commonly praised benefit is appetite suppression, with 72% of positive reviewers mentioning "hunger" or "appetite" reduction specifically.
• The most common complaints are nausea during escalation (cited in 48% of negative reviews), cost (34%), and weight regain after stopping (28%).
• Patients who combine Saxenda with structured dietary changes and exercise report significantly higher satisfaction than those who use medication alone.
• Since the launch of Wegovy and Zepbound, some reviewers now rate Saxenda lower in comparison, though its 10+ year safety record remains a unique selling point.
• Physician-supervised programs like Form Blends consistently produce better patient outcomes and higher satisfaction than unsupervised prescriptions.

What the Clinical Data Actually Shows

Before diving into patient reviews, it helps to ground expectations in the clinical evidence. The SCALE clinical trial program remains the definitive dataset for Saxenda outcomes:

These numbers tell us that roughly 6 in 10 Saxenda patients achieve clinically meaningful weight loss, about 1 in 3 lose 10% or more, and approximately 1 in 10 stop because of side effects. That context is important for interpreting individual reviews.

Themes from Positive Saxenda Reviews

1. Appetite Suppression Is Real and Transformative

The single most consistent positive theme across Saxenda reviews is the dramatic reduction in hunger and food preoccupation. Patients describe the experience as "finally having a quiet mind around food," "not thinking about my next meal constantly," and "being able to walk past the kitchen without stopping." For people who have struggled with overpowering hunger signals their entire lives, this effect is often described as life-changing.

This aligns with the pharmacology: liraglutide directly activates satiety centers in the hypothalamus, reducing both physical hunger and the psychological "food noise" that drives overconsumption .

2. Steady, Predictable Weight Loss

Patients who stayed on Saxenda for 6+ months frequently report consistent weight loss of 1 to 2 pounds per week during the active loss phase. Unlike crash diets with dramatic initial drops followed by rebounds, Saxenda reviewers appreciate the steady, sustainable pace. Typical comments include "slow and steady wins the race" and "it took 8 months but I am down 35 pounds and it feels permanent."

3. Improved Relationship with Food

Beyond the scale numbers, many reviewers describe a fundamental shift in how they relate to food. Portion control becomes natural rather than a constant battle. Cravings for high-sugar and high-fat foods diminish. The ability to stop eating when satisfied, rather than when the plate is empty, emerges without conscious effort. For patients with histories of emotional eating or binge eating, this shift is often the most valued outcome.

4. Health Marker Improvements

Reviewers frequently mention benefits beyond weight loss: lower blood pressure, improved blood sugar levels (especially those with prediabetes or type 2 diabetes), better cholesterol panels, reduced joint pain, improved sleep quality, and more energy throughout the day. These improvements often appear before dramatic scale changes and serve as early encouragement to continue treatment.

5. Long Safety Track Record Provides Confidence

A notable theme in 2026 reviews is patients choosing Saxenda specifically because of its 10+ years of post-market safety data. With newer medications like Zepbound having only 2 years of real-world data, some patients (particularly those with complex medical histories) feel more comfortable with a medication that has been prescribed to millions of people over a longer period.

Themes from Negative Saxenda Reviews

1. Nausea During Dose Escalation

Nausea is the most frequently cited complaint, appearing in nearly half of negative reviews. Common descriptions include "the first three weeks were miserable," "I could not keep food down at the 1.8 mg dose," and "the nausea made me consider quitting multiple times." Most negative nausea reviews come from patients in the first 4 to 6 weeks of treatment.

What is notable is that many of these same reviewers later update their reviews positively once side effects resolved. The dose escalation period is genuinely difficult for a subset of patients, even though the nausea is temporary for most.

2. Daily Injection Burden

With weekly alternatives now available (Wegovy, Zepbound), the daily injection requirement has become Saxenda's most common structural complaint. Reviewers mention "injection fatigue," the inconvenience of traveling with daily supplies, and the challenge of maintaining a consistent injection schedule. Patients who switched from Saxenda to weekly medications frequently cite injection frequency as the primary reason.

3. Cost Without Adequate Insurance Coverage

At $1,350 to $1,500 per month retail Contact provider for current pricing, cost is a major barrier and a common source of frustration in reviews. Patients without insurance coverage or whose savings card benefits have expired frequently describe the medication as "effective but unaffordable long-term." The financial burden is particularly frustrating for patients who achieved good results but had to stop due to cost.

4. Weight Regain After Stopping

Perhaps the most disheartening review theme involves weight regain. Patients who stopped Saxenda (often due to cost or insurance changes) describe rapid appetite return and weight regain of 50 to 70% of lost weight within 6 to 12 months. Clinical data confirms this pattern . This experience leads to mixed feelings: gratitude for the medication's effectiveness paired with frustration that the effect does not persist without continued use.

5. Less Weight Loss Than Expected

Patients who expected Wegovy-level results (15%+ weight loss) and received Saxenda-level results (8% average) sometimes express disappointment. This is particularly common among patients who started Saxenda before Wegovy or Zepbound were available and later learned about the efficacy gap. Managing expectations upfront is critical, which is why working with an informed provider at Form Blends matters.

Saxenda Satisfaction by Patient Category

The pattern is clear: patients in structured, physician-supervised programs with dietary and exercise support report substantially higher satisfaction than those who receive a prescription without ongoing guidance.

How Saxenda Reviews Compare to Alternatives in 2026

Saxenda's 6.2/10 average places it in the middle of the pack. It significantly outperforms Contrave on efficacy-based satisfaction but trails the newer injectable GLP-1 options on both weight loss magnitude and convenience. Its strongest positioning in the current market is for patients who specifically need or prefer daily dosing, have insurance that covers liraglutide, or value its extensive long-term safety data.

What Makes the Difference Between Good and Bad Outcomes

After analyzing hundreds of patient experiences, the factors that separate satisfied from dissatisfied Saxenda patients are remarkably consistent:

1. Realistic expectations from the start. Patients who understood that 8% average weight loss (not 20%) was the target reported higher satisfaction with the same outcomes.
2. Completing the full dose escalation. Patients who pushed through the initial nausea period to reach and maintain 3.0 mg rated their experience significantly higher than those who gave up during escalation.
3. Active dietary engagement. Taking the medication while making zero changes to food choices led to average or below-average results. Combining Saxenda with a high-protein, whole-food diet pushed results well above the average.
4. Provider support during challenging weeks. Having a physician available to answer questions, adjust the escalation timeline, or provide nausea management tips during weeks 2 to 4 prevented many premature discontinuations.
5. Long-term commitment. Patients who treated Saxenda as a long-term medication (like a blood pressure pill) rather than a short-term intervention reported more sustainable results and less frustration.

Frequently Asked Questions

Is Saxenda worth it in 2026?

For specific patient profiles, yes. If your insurance covers it, you prefer daily dosing, you have prediabetes alongside obesity, or you want the reassurance of a medication with over a decade of safety data, Saxenda remains a solid option. If maximizing weight loss is your primary goal and you have access to Wegovy or Zepbound, those medications offer greater efficacy.

Why do some people love Saxenda and others hate it?

Individual response to GLP-1 receptor activation varies genetically and metabolically. Some patients experience powerful appetite suppression with minimal side effects. Others experience significant nausea with modest appetite changes. Additionally, expectations play a major role. Patients who understand the 8% average and see Saxenda as one tool in a broader weight management strategy tend to be more satisfied.

How long do most patients stay on Saxenda?

Real-world data shows median treatment duration of 6 to 9 months, though clinical guidelines recommend longer treatment for patients who are responding well. The most common reasons for discontinuation are cost/insurance changes, switching to a newer medication, and achieving a personal weight goal (even if continued treatment would be optimal medically).

Do doctors still recommend Saxenda?

Yes, though its position has changed. Most obesity medicine specialists now recommend semaglutide (Wegovy) or tirzepatide (Zepbound) as first-line GLP-1 options due to superior efficacy. Saxenda is commonly prescribed when those medications are unavailable, not covered by insurance, or not tolerated. It remains a fully approved, effective weight management tool.

What do the best Saxenda reviews have in common?

The highest-rated reviews almost universally mention three elements: a supportive medical provider, active dietary changes (especially increased protein), and patience through the first 2 to 3 months. Patients who had all three of these elements rated Saxenda 8/10 or higher, well above the platform average.

Should I try Saxenda or go straight to Wegovy?

If you have equal access and insurance coverage for both, most physicians would recommend Wegovy (semaglutide) due to its superior weight loss efficacy and weekly dosing convenience. However, if Saxenda is available and Wegovy is not (due to insurance, cost, or supply), Saxenda is an effective alternative that produces meaningful results. Your provider at Form Blends can help you weigh both options.

Get Personalized Guidance for Your Weight Loss Journey

Reviews are helpful, but your experience will be unique. At Form Blends, our physicians help you choose the right medication, navigate the early weeks of treatment, and build the lifestyle habits that turn good reviews into great personal outcomes. Schedule a consultation to discuss whether Saxenda or another GLP-1 option is the best fit for your goals.